Growthink Research’s Healthcare Venture Capital Report (4Q 03) analyzes and profiles the 138 healthcare companies that raised venture capital in the fourth quarter of 2003 (representing $2.0 billion) and the 230 investors that funded them. All company and investor profiles include complete contact information.
The report is organized by 4 key subsectors:
Biotechnology/Pharmaceutical
Diagnostic/Patient Care
Healthcare Software & Services
Medical Devices
The Report provides many benefits to several audiences:
Early Stage Ventures: unique insight into the funding market; identification of the best investors to target; identification of potential partners; critical competitive intelligence.
Venture Capitalists: critical competitive intelligence for decision-making regarding current portfolio and new investments.
Mid-Stage and Late-Stage/Fortune 500 Companies: critical competitive intelligence and identification of potential ventures to invest in, partner with, or acquire.
Product & Service Providers: identification of the most promising ventures that could use your products and services.